Successfully reported this slideshow.
Your SlideShare is downloading. ×

OS16 - 2.P3.a The Role of Asymptomatic Carriers in FMD Ecology; Unifying Knowledge from Controlled Laboratory Experiments and Filed Studies - J. Arzt

Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad

Check these out next

1 of 34 Ad

OS16 - 2.P3.a The Role of Asymptomatic Carriers in FMD Ecology; Unifying Knowledge from Controlled Laboratory Experiments and Filed Studies - J. Arzt

Download to read offline

OS16 - Open Session 2016
Cascais, Portugal
26 - 28 /10/2016

EuFMD Sessions\Open Session\Archive-2018\Open 2016 Cascais- Portugal\PPT presentations\

OS16 - Open Session 2016
Cascais, Portugal
26 - 28 /10/2016

EuFMD Sessions\Open Session\Archive-2018\Open 2016 Cascais- Portugal\PPT presentations\

Advertisement
Advertisement

More Related Content

Slideshows for you (20)

Similar to OS16 - 2.P3.a The Role of Asymptomatic Carriers in FMD Ecology; Unifying Knowledge from Controlled Laboratory Experiments and Filed Studies - J. Arzt (20)

Advertisement

More from EuFMD (20)

Recently uploaded (20)

Advertisement

OS16 - 2.P3.a The Role of Asymptomatic Carriers in FMD Ecology; Unifying Knowledge from Controlled Laboratory Experiments and Filed Studies - J. Arzt

  1. 1. The role of asymptomatic carriers in FMD ecology; unifying knowledge from controlled laboratory experiments and field studies Jonathan Arzt Veterinary Medical Officer Foreign Animal Disease Research Unit ARS, USDA Plum Island Animal Disease Center Jonathan Arzt, Luis Rodriguez, Barbara Brito, Carolina Stenfeldt
  2. 2. field studies laboratory experiments
  3. 3. • Van Bekkum et al., 1959 • Recovery of infectious FMDV in OPF (saliva) up to 8 months after recovery from clinical FMD • Similar subclinical persistence found in vaccinated cattle • Reports that FMDV carriers do not transmit infection further • Sutmoller and Gaggero, 1965 • Standardization of probang sampling technique • Although, similar approach as used by van Bekkum • Burrows 1966 • Isolation of infectious FMDV from nasopharyngeal tissues of persistently infected cattle • Sutmoller et al 1968 • Definition of carriers at 28dpi The FMDV Carrier State; early landmark papers
  4. 4. First description of carrier state; Van Bekkum et al., 1959
  5. 5. Experimental studies Advantages • Prospective study design • Controlled environment • Known virus and exposure conditions • Strategic & intensive sampling • Possible to reduce/control confounding variables • No delays in sample processing • Reduced operator variability • Provides detailed knowledge of FMDV pathogenesis Limitations
  6. 6. Detecting and defining carriers
  7. 7. Days post infection FMDVGCN/ml Non-Vaccinated cattle Clinical FMD FMDV persistence FMDV “’shedding’” in oral/nasal swabs and probangs Stenfeldt et al 2016 +qRT-PCR/+VI
  8. 8. Sutmoller et al 1968
  9. 9. Vaccinated cattle Divergence at 10 dpi Stenfeldt et al 2016 FMDV persistence definition; from laboratory data
  10. 10. FMDV shedding in tonsil swabs and probangs Maree et al ‘16
  11. 11. Experimental studies Limitations • Experimental capacity (practical burden) • Restrictions in animal numbers and duration of investigations • Logistics and Animal Welfare concerns • Questionable applicability to field situation • Virus used • Environmental conditions • Findings limited to experimental virus strain/host species • Feed • husbandry
  12. 12. FMDV persistence definition; from modeling field data Bronsvoort et al Predictive statistical models for identifying persistently infected cattle:
  13. 13. Advantages • Scale, scope, and duration unlimited • Undeniable link to reality • Enables association of specific findings and known events • Risk analysis based on actual • Spatiotemporal relationships of viruses and outbreaks • Retrospective estimation of transmission pathways • Multi-factorial analysis  FMD Epidemiology & Ecology Limitations • Unknown (uncontrolled) background context • Limited information available • Outcome and conclusions specific to geographic region investigated • Intrinsic technical challenges(cold chain, transport) • Limited capability (no daily sampling, operator variability) • Breadth of relevance difficult to ascertain Field studies
  14. 14. 2 new criteria to characterize the carrier state Bronsvoort et al Stenfeldt et al 2016 Unified Comprehensive
  15. 15. Sites of infection in carriers
  16. 16. Anatomic localization of persistent FMDV: Nasopharynx Dorsal nasopharynx Dorsal soft palate Not the oropharynx.
  17. 17. Anatomic localization of persistent FMDV in the bovine nasopharyngeal mucosa Cytokeratin, FMDV VP1, FMDV 3D, MHC II Stenfeldt et al 2016
  18. 18. Anatomic localization of persistent FMDV Submandibular LN, 38 dpc Juleff et al., Plos ONE (2008) Not mutually exclusive findings.
  19. 19. Anatomic confirmation from the field; Nasopharynx of Asian buffalo Ranjan et al, in progress FMDV Cytokeratin
  20. 20. Duration of carrier state
  21. 21. Duration of FMDV persistence (extinction) Meta-analysis of published experimental studies Decrease in proportion positive animals: 0.11 per carrier month Tenzin et al., 2008
  22. 22. Hayer et al., Duration of FMDV carrier state based on detection of FMDV RNA in probang samples from two farms in Uttarakhand, India Duration of FMDV persistence: field confirmation Bronswoort et al., Unlikely to detect probang-positive animals (by VI) >12 months post- outbreak India (field-based) Cameroon (field-based)
  23. 23. Viral genomic changes during the carrier state
  24. 24. Experimental studies Fig 2. Synonymous (grey) and non-synonymous (black) changes in the ORF of the genomes of the FMD viruses obtained from carrier animals. Parthiban et al., 2015
  25. 25. RGD VP1 nucleotide site BC loop GH-loop C terminus Brito et al, submitted Genomic variation; carriers from the field Vietnam
  26. 26. 2014201320122011 B A Clinical Carrier Clinical stage * Clinical stage Host species Location Host species Brito et al, submitted
  27. 27. Transmission during the carrier state
  28. 28. Transmission from FMDV carriers Tenzin et al., 2008: Meta-analysis of FMDV transmission from persistently infected cattle and buffalo 0.0148 infections per carrier per month
  29. 29. Transmission from FMDV carriers No transmission from persistently infected cattle to (4) contact exposed cattle
  30. 30. Transmission from FMDV carriers NO transmission from persistently infected African buffalo to contact exposed cattle
  31. 31. Field trial: Vietnam • NO transmission from persistently infected cattle to contact exposed cattle Transmission from FMDV carriers?
  32. 32. Keeping it real field studies laboratory experiments modeling modeling
  33. 33. Acknowledgements Co-authors: • Luis Rodriguez • Carolina Stenfeldt • Barbara Brito Funding: • FADRU-ARS-USDA (base support) • DTRA-DOD • CEAH-APHIS-USDA (IAA) • Science and Technology Directorate, DHS (IAA; primary animal work) International Collaborators: • Do Huu Dung • Ngo Thanh Long • Rajeev Ranjan • Jitendra K. Biswal • Bramhadev Pattnaik Analytics: • Shivdeep Hayer • Kimberly VanderWaal • Amy Delgado
  34. 34. Keeping it real field studies laboratory experiments?

×